Board meeting on 6 November 2026 to approve September quarter and half-year results
Board meeting fixed for Friday, 6 November 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Friday, 6 November 2026
- Agenda
- Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended 30 September 2026
- Trading Window Closure
- closed until 9 November 2026
Results date set
The board of Cohance Lifesciences Ltd (formerly Suven Pharmaceuticals Ltd) will meet on Friday, 6 November 2026. The agenda is to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the company for the quarter and half-year ended 30 September 2026.
- Standalone results show the company on its own; consolidated results fold in its subsidiaries.
- The same meeting covers both the three-month quarter and the six-month half-year.
Trading window
The company had written on 28 September 2026 about closing the trading window for designated persons and their immediate relatives.
- That window will remain closed until 9 November 2026.
- During this period, the designated persons and their immediate relatives cannot deal in the company's shares.
Why the window is shut
The trading window is kept closed around a results announcement so that people with inside access to the company do not trade in its shares before the numbers become public. It reopens after the results are taken on record.
What the intimation covers
- The board will look at both standalone and consolidated unaudited results.
- The half-year figures combine the two quarters of the financial year so far.
Bottom line: this is a scheduling intimation. The performance itself will be known when the results are approved and published.
Also from Cohance Lifesciences
Cohance Lifesciences schedules Q2 and H1FY27 results conference call for 6 November 2026
27 Oct 2026
Central Government approves Umang Vohra as Chairman and Group CEO
12 Oct 2026
Grant of 2,60,194 options under ESOP 2026 and 6,14,594 options under ESOP 2023
10 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.